2022 ALS TDI Summit: A Day of Updates on the Progress of ALS Research
- Friday, October 14, 2022
Boston Sheraton Hotel
39 Dalton St, Boston, MA 02199
2022 ALS TDI Summit
Thank you for attending the annual ALS TDI Summit on October 14, 2022, to hear first-hand about the current progress that the ALS Therapy Development Institute (ALS TDI) is making in our research to end ALS. You can read the summary of the event here.
The ALS TDI Summit is a free annual conference hosted by ALS TDI, the Drug Discovery Engine for ALS. The event aims to inform community members and scientists by providing updates on current ALS research. The Summit includes:
- ● Presentations on ALS TDI’s current research led by members of our science team
- ● Guest presentations from leading experts in ALS research
- ● Presentation of the ALS TDI Leadership Awards to members of the community
Event Schedule:
9:00 am BREAKFAST & CHECK IN OPENS (IN-PERSON ONLY)
10:00 am WELCOME ADDRESS / FUELING THE CLINICAL PIPELINE
Presented by Dr. Fernando Vieira, CEO & Chief Scientific Officer
10:30 am LEVERAGING ANIMAL MODELS TO TREAT ALS
Presented by Dr. Theo Hatzipetros, Director of Pharmacology
11:00 am DISCOVERING ALS DISEASE PHENOTYPES IN CELL MODELS
Presented by Anna Gill, Associate Scientist III, Program Manager
11:15 am TURNING CELL PHENOTYPES INTO SCREENS: FINDING THERAPIES AND TARGETS FOR ALS
Presented by Dr. Kyle Denton, Director, Cell Biology
11:30 am THE PMP: HOW YOUR DATA FUELS OUR RESEARCH
Presented by Alan Premasiri, Manager of Clinical Operations/Associate Scientist II
12:00 pm LUNCH & NETWORKING
1:00 pm NEW INNOVATIONS IN ALS THERAPEUTICS
Presented by Dr. Merit Cudkowicz, Director of the Sean M. Healey & AMG Center for ALS, Chief of Neurology at MGH
1:30 pm SHARING HATS: HOW PALS, ADVOCATES, SCIENTISTS, CLINICIANS, AND INDUSTRY ARE IMPROVING ALS THERAPY DEVELOPMENT TOGETHER
Presented by Dr. Lyle Ostrow, ALS clinician and scientist, Temple University
2:00 pm FROM CONCEPT TO CLINICAL TRIALS AND BEYOND
Presented by Josh Cohen and Justin Klee, Co-CEOs & Co-Founders of Amylyx
2:30 pm TEGOPRUBART (AT-1501) IS SAFE AND WELL TOLERATED AND REDUCES INFLAMMATION IN PATIENTS WITH ALS
Presented by Dr. Steven Perrin, President & Chief Scientific Officer, Eledon Pharmaceuticals
3:15 pm LEADERSHIP AWARDS PRESENTATION
Presented by Carol Hamilton, Vice President of Development, ALS TDI
Additional program details will be available soon.
Who Should Attend the ALS TDI Summit?
The ALS TDI Summit is free and is open to all members of the ALS community, including:
- people with ALS
- caregivers
- friends and family members
- members of the ALS research and science community
We hope you can join us at the Summit to learn more about the progress we are making together.
All of our progress to end ALS is thanks to the support of the ALS community.
Thank you to our sponsors of the ALS TDI Leadership Weekend
